Szebeni, J.
714  results:
Search for persons X
?
1

The COVID-19 mRNA vaccine Comirnaty induces anaphylactic sh..:

Barta, B A ; Radovits, T ; Dobos, A B...
European Heart Journal.  44 (2023)  Supplement_2 - p. , 2023
 
?
 
?
3

Hypersensitivity to intravenous iron: classification, termi..:

Szebeni, J ; Fishbane, S ; Hedenus, M...
British Journal of Pharmacology.  172 (2015)  21 - p. 5025-5036 , 2015
 
?
5

Complement mediated hypersensitivity to nanomedicines:

Szebeni, J.
Molecular Immunology.  48 (2011)  14 - p. 1715 , 2011
 
?
6

Effects of rosiglitazone on the configuration of action pot..:

Szentandrássy, N ; Harmati, G ; Bárándi, L...
British Journal of Pharmacology.  163 (2011)  3 - p. 499-509 , 2011
 
?
7

Fc-Receptor-mediated Targeting of Antibody-bearing Liposome..:

Betageri, G V ; Black, C D V ; Szebeni, J..
Journal of Pharmacy and Pharmacology.  45 (2011)  1 - p. 48-53 , 2011
 
?
 
?
 
?
 
?
12

Electrophysiological effects of escitalopram in guinea-pig ..:

Kecskemeti, V. ; Szebeni, A. ; Kiselnik, D..
Journal of Molecular and Cellular Cardiology.  42 (2007)  6 - p. S5 , 2007
 
?
13

Poly(amino acid)s: Promising enzymatically degradable steal..:

ROMBERG, B ; METSELAAR, J ; BARANYI, L...
International Journal of Pharmaceutics.  331 (2007)  2 - p. 186-189 , 2007
 
?
 
?
15

Stealth liposomes and long circulating nanoparticles: criti..:

Moghimi, S.M. ; Szebeni, J.
Progress in Lipid Research.  42 (2003)  6 - p. 463-478 , 2003
 
1-15